Yongin-si, South Korea

Hyung-Kwon Lim



 

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Gyunggi-do, KR (2010)
  • Yongin-si, KR (2012 - 2022)

Company Filing History:


Years Active: 2010-2022

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Hyung-Kwon Lim: A Pioneer in Cancer Therapeutics**

Introduction

Hyung-Kwon Lim, based in Yongin-si, South Korea, is an accomplished inventor holding a remarkable portfolio of seven patents. His innovative work primarily focuses on the development of antibodies for cancer treatment, demonstrating his commitment to advancing biomedical research.

Latest Patents

Among Hyung-Kwon Lim’s latest patents is the invention of an anti-BCMA antibody that exhibits a high affinity for B-cell maturation antigen (BCMA). This novel antibody is designed to treat cancer and is characterized by a heavy chain variable domain composed of sequences homologous to specific amino acid sequences. Another significant patent includes the anti-mesothelin antibody, which also targets mesothelin (MSLN) and is integral for developing effective treatments for cancer or tumor diseases. This invention encompasses the antibody's encoding nucleic acid, vectors, production methods, and pharmaceutical compositions, emphasizing its high specificity and affinity for treating and diagnosing malignancies.

Career Highlights

Hyung-Kwon Lim has had a significant impact in the field of biomedical research through his work at prestigious organizations, including the Mogam Institute for Biomedical Research and The Green Cross Corporation. His contributions to these institutions have reinforced their missions to advance medical science.

Collaborations

Hyung-Kwon Lim has worked alongside esteemed colleagues, such as Dong-Sik Kim and Young Seoub Park. These collaborations have enhanced his research endeavors and enabled advancements in antibody development.

Conclusion

Hyung-Kwon Lim stands out as a notable inventor in the realm of cancer therapeutics. With his extensive portfolio of patents and valuable contributions to the biomedical field, he continues to be a driving force in the pursuit of innovative solutions for cancer treatment. His work not only showcases his ingenuity but also his dedication to improving patient outcomes through scientific discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…